Immunogenicity and Safety of Japanese Encephalitis Chimeric Virus Vaccine (JE CV) Concomitantly Administered With Measles, Mumps, and Rubella (MMR) Vaccine in Toddlers in Taiwan
Phase of Trial: Phase III
Latest Information Update: 15 Oct 2014
At a glance
- Drugs Japanese encephalitis vaccine (Primary) ; Measles mumps and rubella virus vaccine
- Indications Japanese encephalitis; Measles; Mumps; Rubella
- Focus Adverse reactions; Pharmacodynamics
- Sponsors sanofi pasteur
- 11 Mar 2014 Results published in the Vaccine.
- 28 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jan 2012 Planned End Date changed from 1 Jan 2012 to 1 Feb 2013 as reported by ClinicalTrials.gov.